🇺🇸 FDA

Intelligence · Clinical Pipeline

Takeda Pipeline

All ClinicalTrials.gov programs at Takeda — phase, modality, and trial IDs.

Programs
1,179

Quick answer

Takeda has 1,179 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. pioglitazone

    Takeda

    Alzheimer Disease

    phase 2 small molecule completed

    1 trial

  2. ponatinib - Phase 1

    Takeda

    Chronic Myeloid Leukemia (CML)

    phase 2 small molecule completed

    1 trial

  3. rhHNS-10 mg

    Takeda

    Sanfilippo Syndrome

    phase 2 mab terminated

    1 trial

  4. rhIGF-1/rhIGFBP-3

    Takeda

    Retinopathy of Prematurity (ROP)

    phase 2 small molecule completed

    1 trial

  5. rhIGF-I/rhIGFBP-3

    Takeda

    Retinopathy of Prematurity (ROP)

    phase 2 small molecule completed

    1 trial

  6. troxacitabine

    Takeda

    Leukemia

    phase 2 small molecule completed

    1 trial

  7. velaglucerase alfa

    Takeda

    Gaucher Disease, Type 3

    phase 2 mab completed

    1 trial

  8. vortioxetine (Lu AA21004)

    Takeda

    Depressive Disorder, Major

    phase 2 small molecule completed

    1 trial

  9. 19(T2)28z1xx CAR T cells

    Takeda

    Diffuse Large B Cell Lymphoma

    phase 1 small molecule active

    1 trial

  10. 19(T2)28z1xx TRAC T cell

    Takeda

    B-Cell Lymphoma

    phase 1 mab active

    1 trial

  11. 25mcg rhPTH(1-84)

    Takeda

    Hypoparathyroidism

    phase 1 small molecule completed

    1 trial

  12. 30 mg dexlansoprazole capsules manufactured at TOB

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    2 trials

  13. A Study of Mezagitamab in Adults With Primary Immunoglobulin A Nephropathy Receiving Stable Background Therapy

    Takeda

    IgAN is Primary Immunoglobulin A Nephropathy (IgAN) (also known as Berger's disease)

    phase 1 other active

    1 trial

  14. ACTOS (Pioglitazone)

    Takeda

    Multiple Sclerosis, Relapsing-Remitting

    phase 1 small molecule completed

    1 trial

  15. ADCLEC.syn1 CAR T cells

    Takeda

    Acute Myeloid Leukemia

    phase 1 mab active

    1 trial

  16. Adjuvant/Excipients

    Takeda

    Norovirus

    phase 1 small molecule completed

    1 trial

  17. Alisertib

    Takeda

    Advanced Solid Tumors

    phase 1 small molecule completed

    7 trials

  18. Alisertib

    Takeda

    B-cell Follicular Lymphoma

    phase 1 small molecule completed

    1 trial

  19. Alisertib

    Takeda

    Solid Tumors

    phase 1 small molecule completed

    1 trial

  20. Alogliptin

    Takeda

    Pharmacokinetics and Pharmacodynamics

    phase 1 small molecule completed

    1 trial

  21. Alogliptin

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    2 trials

  22. Amoxicillin + MMX placebo

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial

  23. Anagrelide 0.5 mg

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial

  24. Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody

    Takeda

    Metastatic Adenocarcinoma of the Colon or Rectum

    phase 1 mab completed

    1 trial

  25. Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody

    Takeda

    Systemic Lupus Erythematosus

    phase 1 small molecule terminated

    1 trial

  26. Azilsartan medoxomil (TAK-491)

    Takeda

    Hypertension

    phase 1 small molecule terminated

    1 trial

  27. BAX 826

    Takeda

    Hemophilia A

    phase 1 mab completed

    1 trial

  28. Binimetinib

    Takeda

    ALK Gene Rearrangement

    phase 1 small molecule terminated

    1 trial

  29. Brentuximab Vedotin

    Takeda

    Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic

    phase 1 small molecule terminated

    1 trial

  30. Brigatinib

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  31. Budesonide

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  32. Calcichew D3

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  33. Calcitriol

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial

  34. Calcium 500 mg and Vitamin D3 800 IU

    Takeda

    Calcium Deficiency

    phase 1 small molecule completed

    1 trial

  35. Ciprofloxacin XR + MMX Placebo

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial

  36. Clarithromycin

    Takeda

    Helicobacter Pylori

    phase 1 small molecule completed

    2 trials

  37. Clopidogrel

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial

  38. DHAP

    Takeda

    Hodgkin Lymphoma

    phase 1 small molecule active

    1 trial

  39. Danavorexton

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  40. Daratumumab

    Takeda

    Newly Diagnosed Primary Amyloidosis

    phase 1 mab active

    1 trial

  41. Deferitazole (disodium salt, granule)

    Takeda

    Healthy

    phase 1 small molecule terminated

    1 trial

  42. Dexlansoprazole

    Takeda

    Pediatric Gastroesophageal Reflux Disease

    phase 1 small molecule terminated

    1 trial

  43. Dexlansoprazole

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  44. Dexlansoprazole

    Takeda

    Homeostasis

    phase 1 small molecule completed

    1 trial

  45. Dexlansoprazole Delayed Release Orally Disintegrating Tablets

    Takeda

    Bioavailability

    phase 1 small molecule completed

    1 trial

  46. Dexlansoprazole MR

    Takeda

    Gastroesophageal Reflux

    phase 1 small molecule completed

    1 trial

  47. Digoxin

    Takeda

    Cytomegalovirus (CMV)

    phase 1 small molecule completed

    1 trial

  48. Dose of 60 mg/kg Fraction IV-1 Alpha1-Proteinase Inhibitor

    Takeda

    Alpha 1-Antitrypsin Deficiency

    phase 1 mab completed

    1 trial

Frequently asked questions

How many pipeline programs does Takeda have?

1,179 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.